Annual Current Ratio
2.85
-1.11-28.03%
31 December 2023
Summary:
Adaptimmune Therapeutics annual current ratio is currently 2.85, with the most recent change of -1.11 (-28.03%) on 31 December 2023. During the last 3 years, it has fallen by -7.34 (-72.03%). ADAP annual current ratio is now -74.14% below its all-time high of 11.02, reached on 30 June 2015.ADAP Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
3.85
+0.76+24.60%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly current ratio is currently 3.85, with the most recent change of +0.76 (+24.60%) on 30 September 2024. Over the past year, it has increased by +0.93 (+31.85%). ADAP quarterly current ratio is now -68.52% below its all-time high of 12.23, reached on 30 September 2020.ADAP Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.0% | +31.9% |
| 3 y3 years | -72.0% | -47.3% |
| 5 y5 years | -69.9% | -2.0% |
ADAP Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.0% | at low | -47.3% | +37.0% |
| 5 y | 5 years | -72.0% | at low | -68.5% | +37.0% |
| alltime | all time | -74.1% | +612.5% | -68.5% | +277.4% |
Adaptimmune Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 3.85(+24.6%) |
| June 2024 | - | 3.09(+10.0%) |
| Mar 2024 | - | 2.81(-1.4%) |
| Dec 2023 | 2.85(-28.0%) | 2.85(-2.4%) |
| Sept 2023 | - | 2.92(-15.1%) |
| June 2023 | - | 3.44(+2.4%) |
| Mar 2023 | - | 3.36(-15.2%) |
| Dec 2022 | 3.96(-40.4%) | 3.96(-1.0%) |
| Sept 2022 | - | 4.00(-8.3%) |
| June 2022 | - | 4.36(-19.7%) |
| Mar 2022 | - | 5.43(-18.2%) |
| Dec 2021 | 6.64(-34.8%) | 6.64(-9.0%) |
| Sept 2021 | - | 7.30(-10.4%) |
| June 2021 | - | 8.15(-29.0%) |
| Mar 2021 | - | 11.48(+12.7%) |
| Dec 2020 | 10.19(+190.3%) | 10.19(-16.7%) |
| Sept 2020 | - | 12.23(+2.9%) |
| June 2020 | - | 11.88(+55.5%) |
| Mar 2020 | - | 7.64(+117.7%) |
| Dec 2019 | 3.51 | 3.51(-10.7%) |
| Sept 2019 | - | 3.93(-36.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | 6.19(-27.6%) |
| Mar 2019 | - | 8.55(-9.6%) |
| Dec 2018 | 9.46(+205.2%) | 9.46(+6.9%) |
| Sept 2018 | - | 8.85(+131.7%) |
| June 2018 | - | 3.82(+1.3%) |
| Mar 2018 | - | 3.77(+21.6%) |
| Dec 2017 | 3.10(-37.2%) | 3.10(-16.2%) |
| Sept 2017 | - | 3.70(-52.9%) |
| June 2017 | - | 7.86(+12.4%) |
| Mar 2017 | - | 6.99(+41.5%) |
| Dec 2016 | 4.94(-47.6%) | 4.94(-43.9%) |
| Sept 2016 | - | 8.81(-18.7%) |
| June 2016 | - | 10.83(-10.0%) |
| Mar 2016 | - | 12.03(+41.2%) |
| Dec 2015 | 9.43(-14.4%) | - |
| Sept 2015 | - | 8.52(+189.8%) |
| June 2015 | 11.02(+980.4%) | - |
| Dec 2014 | - | 2.94(+188.2%) |
| June 2014 | 1.02(+155.0%) | 1.02 |
| June 2013 | 0.40(-57.9%) | - |
| June 2012 | 0.95 | - |
FAQ
- What is Adaptimmune Therapeutics annual current ratio?
- What is the all time high annual current ratio for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual current ratio year-on-year change?
- What is Adaptimmune Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly current ratio year-on-year change?
What is Adaptimmune Therapeutics annual current ratio?
The current annual current ratio of ADAP is 2.85
What is the all time high annual current ratio for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual current ratio is 11.02
What is Adaptimmune Therapeutics annual current ratio year-on-year change?
Over the past year, ADAP annual current ratio has changed by -1.11 (-28.03%)
What is Adaptimmune Therapeutics quarterly current ratio?
The current quarterly current ratio of ADAP is 3.85
What is the all time high quarterly current ratio for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly current ratio is 12.23
What is Adaptimmune Therapeutics quarterly current ratio year-on-year change?
Over the past year, ADAP quarterly current ratio has changed by +0.93 (+31.85%)